PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Polysaccharides (PSP and PSK) are used as adjuvant therapy to improve survival and quality of life in cancer patients [PMID:32466253, PMID:31030754].
Findings demonstrate antiproliferative, pro-apoptotic, and immunomodulatory effects; one phase I trial reported good tolerability [PMID:41150756, PMID:19087769].
Systematic review of PSK for lung cancer included 6 RCTs and 5 nonrandomized trials, with 15 of 17 preclinical studies supporting anticancer effects [PMID:25784670].
Extracts show strong cell growth inhibitory activity on human colorectal tumor cells [PMID:36359361].
A retrospective cohort study found HPV clearance was significantly higher in a group treated with a Coriolus versicolor-based vaginal gel (89.3% vs 44.7%) [PMID:42187868].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37513265 (2023) — Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production-A Review. · Molecules (Basel, Switzerland)
- 2.PMID: 32466253 (2020) — Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy. · Biomedicines
- 3.PMID: 28267306 (2002) — Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. · Recent patents on inflammation & allergy drug discovery
- 4.PMID: 27929633 (2002) — Trametes versicolor carboxylate reductase uncovered. · Monatshefte fur chemie
- 5.PMID: 36827712 (2023) — The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro.